Accelerate Diagnostics
AXDX
$0.86
Share price
11.56%
Change (1 day)
26.32%
Change (1 year)
Categories
Accelerate Diagnostics (AXDX) - Total liabilities
Total liabilities on the balance sheet as of September 2023 : $74.35 M
According to Accelerate Diagnostics's latest financial reports the company's total liabilities are $74.35 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Accelerate Diagnostics - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $87.27 M | -26.11% |
| 2021-12-31 | $0.11 B | -24.4% |
| 2020-12-31 | $0.15 B | 10.18% |
| 2019-12-31 | $0.14 B | 10.88% |
| 2018-12-31 | $0.12 B | 1778.53% |
| 2017-12-31 | $6.8 M | 35.19% |
| 2016-12-31 | $5.03 M | -20.14% |
| 2015-12-31 | $6.3 M | 65.51% |
| 2014-12-31 | $3.81 M | 99.06% |
| 2013-12-31 | $1.91 M | |
| 2012-07-31 | $2.37 M | 64.14% |
| 2011-07-31 | $1.44 M | 6.6% |
| 2010-07-31 | $1.35 M | 1.66% |
| 2009-07-31 | $1.33 M | -5.48% |
| 2008-07-31 | $1.41 M | 12.45% |
| 2007-07-31 | $1.25 M | 13.43% |
| 2006-07-31 | $1.1 M | -17.23% |
| 2005-07-31 | $1.33 M | 35.59% |
| 2004-07-31 | $0.98 M | -2.77% |
| 2003-07-31 | $1.01 M | -20.56% |
| 2002-07-31 | $1.27 M | 14.19% |
| 2001-07-31 | $1.12 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $51.88 B | 69,676.89% | 🇺🇸 USA |
 Becton Dickinson BDX | $26.94 B | 36,131.96% | 🇺🇸 USA |
 PerkinElmer
PKI | $6.60 B | 8,781.93% | 🇺🇸 USA |
 Bruker BRKR | $2.83 B | 3,714.84% | 🇺🇸 USA |
 NanoString Technologies NSTG | $0.32 B | 337.46% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | $3.55 B | 4,684.94% | 🇺🇸 USA |